Related Experiment Video

Updated: May 30, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus

D Pineles1, A Valente, B Warren

  • 1Yeshiva University, New York, NY, USA.

Lupus
|July 20, 2011
PubMed

Insights

Worldwide data on pediatric-onset systemic lupus erythematosus (SLE) is scarce. This review highlights the need for more global research to understand the full scope of childhood SLE.

Area of Science:

  • Rheumatology
  • Pediatrics
  • Epidemiology

Background:

  • Pediatric-onset systemic lupus erythematosus (SLE) is a significant autoimmune condition.
  • Understanding the global incidence and prevalence of childhood SLE is crucial for public health.
  • Current data on pediatric SLE epidemiology is limited and geographically concentrated.

Purpose of the Study:

  • To compile and unify existing global data on the incidence and prevalence of pediatric-onset SLE.
  • To assess the current scope of pediatric SLE worldwide.
  • To identify gaps in epidemiological research for childhood SLE.

Main Methods:

  • A comprehensive literature review was conducted.
  • Epidemiological studies focusing on pediatric-onset SLE incidence and prevalence were systematically examined.
  • Data from 13 relevant studies were analyzed.

Main Results:

  • The reviewed studies were primarily concentrated in North America, Europe, and Asia.
  • A limited number of epidemiological studies on pediatric SLE were identified globally.
  • Significant geographical disparities exist in the available research.

Conclusions:

  • There is a critical need for expanded epidemiological research on pediatric-onset SLE globally.
  • More comprehensive data is required to accurately assess the worldwide burden of childhood SLE.
  • Further research will facilitate better understanding and management of pediatric SLE.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...